The SRS at Daresbury Laboratory in the UK was the world’s first dedicated synchrotron light source facility. It opened in 1980 and delivered worldwide impact and two Nobel Prizes.
The first of its kind, the SRS enabled research that has improved the quality of our lives in so many ways. This included research into diseases such as HIV and AIDS, as well as motor neurone disease, to name just a few examples. The structure of the Foot & Mouth virus was solved for the first time at the SRS – it was the first animal virus structure to be determined in Europe and led to the development of a vaccine. The huge magnetic memory of the Apple iPod was also the result of research carried out on the SRS. However, its most famous achievement was the key role it played towards a share of two Nobel Prizes in Chemistry. One to Sir John Walker in 1997, for solving a structure of an enzyme that opened the way for new insights into metabolic diseases, and the other to Sir Venki Ramakrishnan in 2009, for his work on the structure and function of the Ribosome, the particle responsible for protein synthesis in living cells.
During its lifetime, the SRS created a critical mass of highly skilled engineers and technicians at Daresbury Laboratory, with specialisms ranging from detectors to magnets and electronics, and by the time it closed in 2008, it had collaborated with almost every country active in scientific research. It had hosted over 11,000 users from academia, government laboratories and industry worldwide, leading to the publication of more than 5000 research papers, resulting in numerous patents. The economic impact of this was vast on a worldwide scale, but it also played an important role in boosting the regional economy of the North West, having worked with hundreds of local businesses.
The success of the SRS led to the development of many similar machines around the world, with the technologies and skills developed still in use at many facilities today, including its UK successor, the Diamond Light Source at Harwell Science and Innovation Campus in Oxfordshire. It also led to the establishment of ASTeC, a leading centre for accelerator science and technology at Daresbury Laboratory, and the Cockcroft Institute, a joint venture between STFC and the Universities of Lancaster, Liverpool, Manchester and Strathclyde. It is also home to CLARA, a unique particle accelerator designed to develop, test and advance accelerator technologies of the future. Research carried out by accelerator scientists at Daresbury has had many impacts, particularly in the health and medicine arena, including work to develop our next generation of proton imaging technology for cancer detection, and research that could one day lead to more efficient diagnoses of cervical, oesophageal, and prostate cancers. In the footsteps of senior scientist, Professor Ian Munro, who was responsible for the plan to build the SRS and for its operation at Daresbury, ASTeC’s accelerator scientists and engineers continue to play a key role in designing, building and upgrading the world’s newest generations of accelerator facilities.
Read more on the STFC/UKRI website
Image: The SRS control room